Korean Drug Statistics

Total Valuation

Korean Drug has a market cap or net worth of KRW 51.61 billion. The enterprise value is 31.56 billion.

Market Cap	51.61B
Enterprise Value	31.56B

Important Dates

The last earnings date was Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Korean Drug has 10.91 million shares outstanding. The number of shares has decreased by -0.75% in one year.

Current Share Class	n/a
Shares Outstanding	10.91M
Shares Change (YoY)	-0.75%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	50.60%
Owned by Institutions (%)	0.02%
Float	5.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.68
PB Ratio	0.64
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.72, with an EV/FCF ratio of -2.12.

EV / Earnings	-81.01
EV / Sales	0.42
EV / EBITDA	13.72
EV / EBIT	127.68
EV / FCF	-2.12

Financial Position

The company has a current ratio of 6.87, with a Debt / Equity ratio of 0.00.

Current Ratio	6.87
Quick Ratio	4.56
Debt / Equity	0.00
Debt / EBITDA	0.03
Debt / FCF	-0.00
Interest Coverage	70.20

Financial Efficiency

Return on equity (ROE) is -0.48% and return on invested capital (ROIC) is 0.19%.

Return on Equity (ROE)	-0.48%
Return on Assets (ROA)	0.15%
Return on Capital (ROIC)	0.19%
Revenue Per Employee	275.59M
Profits Per Employee	-1.44M
Employee Count	270
Asset Turnover	0.73
Inventory Turnover	1.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.15%
50-Day Moving Average	4,729.20
200-Day Moving Average	5,580.80
Relative Strength Index (RSI)	53.54
Average Volume (20 Days)	55,802

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Korean Drug had revenue of KRW 74.41 billion and -389.58 million in losses. Loss per share was -36.26.

Revenue	74.41B
Gross Profit	36.39B
Operating Income	247.18M
Pretax Income	1.18B
Net Income	-389.58M
EBITDA	2.30B
EBIT	247.18M
Loss Per Share	-36.26

Full Income Statement

Balance Sheet

The company has 20.13 billion in cash and 72.26 million in debt, giving a net cash position of 20.05 billion or 1,837.75 per share.

Cash & Cash Equivalents	20.13B
Total Debt	72.26M
Net Cash	20.05B
Net Cash Per Share	1,837.75
Equity (Book Value)	80.36B
Book Value Per Share	7,448.26
Working Capital	58.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.20 billion and capital expenditures -1.69 billion, giving a free cash flow of -14.90 billion.

Operating Cash Flow	-13.20B
Capital Expenditures	-1.69B
Free Cash Flow	-14.90B
FCF Per Share	-1,365.10

Full Cash Flow Statement

Margins

Gross margin is 48.91%, with operating and profit margins of 0.33% and -0.52%.

Gross Margin	48.91%
Operating Margin	0.33%
Pretax Margin	1.58%
Profit Margin	-0.52%
EBITDA Margin	3.09%
EBIT Margin	0.33%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 3.17%.

Dividend Per Share	150.00
Dividend Yield	3.17%
Dividend Growth (YoY)	-16.67%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.75%
Shareholder Yield	3.92%
Earnings Yield	-0.77%
FCF Yield	-28.86%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Korean Drug has an Altman Z-Score of 5.79.

Altman Z-Score	5.79
Piotroski F-Score	n/a